Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2025-12-25 @ 2:33 AM
NCT ID:
NCT03433534
Eligibility Criteria:
Inclusion Criteria:
* Patient with squamous or non squamous non small cell lung cancer stage IV or patient with renal cell carcinoma stage IV
* Patient receiving nivolumab or who will receive nivolumab
* Age ⩾ 18 years old
* OMS stage ≤ 2
* Evaluable disease
Exclusion Criteria:
* Active brain metastasis not treated before by surgery or radiotherapy
* Autoimmune disease
* Patient having objected to the processing of his data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03433534
Study Brief:
Protocol Section:
NCT03433534